New test could flag which men need aggressive prostate cancer treatment and which don't
The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy and which can skip it.
The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy and which can skip it.
Read the full article on Fox News
Read Full Article →